Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Last 14 days
Addictions Neuroclinical Assessment
Computer-Assisted Self-Administration of Ethanol (CASE) in Humans
Development of Neuroimaging Methods to Assess the Neurobiology of Addiction
Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness
Characterization Imaging Instruments for Addiction Neuroimaging Assessments
(Epi)Genetic Modulators of Fear Extinction in Alcohol Dependence
Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)
Characterization of Brain Amyloid-beta (A-beta) Retention During Wakefulness And Following Emergence From Sleep In Healthy Subjects
Role of Metal Ion Transporter ZIP8 in Alcohol Related Behaviors
Brain Dopaminergic Signaling in Opioid Use Disorders (OUD)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)